The Journal of Pediatrics
Volume 145, Issue 3 , Pages 297-303, September 2004

Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants

From Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Instituto National de Ciencias Medicas y Nutrition, Mexico DF, Mexico; Shriver Center, University of Massachusetts Medical School, Waltham, Massachusetts; and Centers for Disease Control and Prevention, Atlanta, Georgia USA

Received 10 February 2003; received in revised form 22 March 2004; accepted 19 April 2004.

See related article, p 308.

Abstract 

Objective

To determine the association between maternal milk levels of 2-linked fucosylated oligosaccharide and prevention of diarrhea as a result of Campylobacter, caliciviruses, and diarrhea of all causes in breast-fed infants.

Study design

Data and banked samples were analyzed from 93 breast-feeding mother-infant pairs who were prospectively studied during 1988-1991 from birth to 2 years with infant feeding and diarrhea data collected weekly; diarrhea was diagnosed by a study physician. Milk samples obtained 1 to 5 weeks postpartum were analyzed for oligosaccharide content. Data were analyzed by Poisson regression.

Results

Total 2-linked fucosyloligosaccharide in maternal milk ranged from 0.8 to 20.8 mmol/L (50%-92% of milk oligosaccharide). Moderate-to-severe diarrhea of all causes (n=77 cases) occurred less often (P=.001) in infants whose milk contained high levels of total 2-linked fucosyloligosaccharide as a percent of milk oligosaccharide. Campylobacter diarrhea (n=31 cases) occurred less often (P=.004) in infants whose mother's milk contained high levels of 2′-FL, a specific 2-linked fucosyloligosaccharide, and calicivirus diarrhea (n=16 cases) occurred less often (P=.012) in infants whose mother's milk contained high levels of lacto-N-difucohexaose (LDFH-I), another 2-linked fucosyloligosaccharide.

Conclusion

This study provides novel evidence suggesting that human milk oligosaccharides are clinically relevant to protection against infant diarrhea.

Abbreviations:  2′FL, 2′fucosyllactose, 3-FL, 3-fucosyllactose, LNF-I, Lacto-N-fuco-pentaose I, LNF-II, Lacto-N-fuco-pentaose II, LDFH-I, Lacto-N-difucohexaose, LDFT, Lactodifucotetraose, LNneoT, Lacto-N-neotetraose, LNT, Lacto-N-tetraose

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the National Institute of Child Health and Human Development (HD13021) and Cincinnati Children's Research Foundation.

PII: S0022-3476(04)00375-0

doi:10.1016/j.jpeds.2004.04.054

The Journal of Pediatrics
Volume 145, Issue 3 , Pages 297-303, September 2004